DOD Pancreatic Cancer, Idea Development Award

Active
Yes
Status
Posted
Published Date
April 29th, 2024
Close Date
October 3rd, 2024
Total Funding
$7,360,000.00
Expected No. Awards
8
Opportunity No.
HT942524PCARPIDA

Agency

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The Department of the Army -- USAMRAA is offering a grant opportunity titled "DOD Pancreatic Cancer, Idea Development Award". This grant aims to support the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. The grant seeks to fund projects that make important and original contributions to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for patients. The research should be innovative and may challenge existing paradigms or utilize new perspectives, methods, or technologies. The grant encourages the inclusion of personnel with experience in pancreatic cancer research and the use of preliminary data to support the proposed research. Additionally, the grant offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. The deadline for application submission is October 3, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.

Description

The PCARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.Significant features of the Idea Development Award:Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for individuals with pancreatic cancer. The project’s impact on both pancreatic cancer research and patient care should be articulated, even if clinical impact is not an immediate outcome.Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative.Personnel: Personnel are considered a crucial element of the FY24 PCARP Idea Development Award. At least one member of the research team should have experience in pancreatic cancer research, as demonstrated by recent publications and funding. Inclusion of a biostatistician in the study team is encouraged.Research must be based on preliminary data: Although the proposed research must have direct relevance to pancreatic cancer, the required preliminary data, which may include unpublished results from the laboratory of the Principal Investigator(s) (PI[s]), research team, or collaborators named on the application, may be from outside the pancreatic cancer research field. Research should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.Partnering PI Option for Early-Career Investigator: The FY24 Idea Development Award mechanism is offering a higher level of funding for applications that propose to partner an experienced PI (i.e., Initiating PI, who will serve as the mentor) with an Early-Career Investigator (i.e., Partnering PI) wishing to pursue a career in pancreatic cancer research. The Initiating PI on the Idea Development Award must mentor and collaborate with the Early-Career Investigator (Partnering PI) to promote their career development in pancreatic cancer research. The Early-Career Investigator must meet the specific eligibility criteria described in Section II.C, Eligibility Information. The Initiating PI will be responsible for the majority of the administrative tasks associated with application submission. The Initiating and Partnering PIs each have different submission requirements, as described in Section II.D.2, Content and Form of the Application Submission; however, both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. If recommended for funding, each PI will be named to an individual award within the recipient organization. Projects involving convergence science partnerships are encouraged.

Contact Information

Attachments
137 KB
545 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

DOD Pancreatic Cancer, Focused Pilot Award
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DOD Pancreatic Cancer, Focused Pilot Award". This grant aims to support impactful and innovative concepts in pancreatic cancer research that can lead to significant advancements in patients' overall quality of life. The grant is focused on two patient-centered areas of research: access to healthcare and mental health/cancer-related outcomes and quality of life. The grant encourages studies on behaviors affecting access to healthcare, correlations between mental health and cancer outcomes, strategies to overcome psycho-social issues, behavioral studies on quality of life and decision-making, and development of nutritional or educational interventions for symptom management. The grant does not require preliminary data but expects a well-formulated, testable hypothesis based on strong scientific rationale. Clinical research studies are allowed, but interventional clinical trials, basic research, and preclinical animal studies are not supported. The proposed research should have a significant impact on improving outcomes and quality of life for individuals with pancreatic cancer. Innovation in study concept, research methods or technology, and adaptations of existing methods or technologies is highly encouraged. The grant has an estimated total program funding of $1,280,000 and expects to make 4 awards. The closing date for applications is October 3, 2024. For more information, you can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Rare Cancers, Idea Development Award
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Rare Cancers, Idea Development Award". This grant aims to promote new ideas in the early stages of development that have the potential to yield impactful data and new avenues of investigation for rare cancers. The grant supports research with preliminary data that could lead to critical discoveries or major advancements in eradicating deaths and suffering from rare cancers. The grant encourages innovative research involving nuclear medicine and related techniques to improve diagnosis, treatment, and health outcomes for active-duty Service Members and their Families. It also encourages research on health areas and conditions that affect women uniquely or differently from men. The grant does not allow clinical trials and emphasizes adherence to rigorous study design and reporting standards. Applications from investigators within the military services and collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs, and other federal government agencies are highly encouraged. The close date for this grant opportunity is September 26, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Peer Reviewed Cancer, Idea Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Peer Reviewed Cancer, Idea Award". This grant aims to support innovative and high-risk concepts, theories, paradigms, and basic cancer research. The funding of $16,000,000 is expected to result in approximately 20 awards. The Idea Award is specifically designed to encourage research that introduces new paradigms, challenges existing ones, and offers highly creative approaches to cancer research. It is not intended to support incremental advances or logical progressions of established projects. The proposed research should have a well-formulated, testable hypothesis based on strong scientific rationale and study design, and generate robust preliminary data. Inclusion of preliminary data is discouraged as this award focuses on exploratory research. Researchers are encouraged to select the most appropriate funding opportunity for their proposed research. For more information, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. The deadline for submission is September 26, 2024, and the archive date is October 26, 2024.
DoD Prostate Cancer, Idea Development Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Prostate Cancer, Idea Development Award". This grant aims to support innovative approaches to prostate cancer research that have the potential to make a significant contribution to the Prostate Cancer Research Program (PCRP) mission. The key components of this grant include innovation, impact, and the presentation of preliminary data. The research should be innovative, challenging current paradigms, and offering new perspectives. It should also address and provide a solution to one or more of the FY24 PCRP Overarching Challenges. The potential impact of the research in advancing prostate cancer research and patient care should be clearly described. The grant encourages research ideas from investigators in the early stages of their careers through the New Investigator category. Collaborators with experience in prostate cancer research are required, and a letter of collaboration is strongly encouraged. Multidisciplinary and multi-institutional projects are also encouraged, with a focus on communication, coordination, and data transfer among team members and organizations. The proposed research should incorporate components such as authentication of proposed cell lines, statistical rigor of preclinical animal experiments, and experiments to assess clinical relevance and translatability of findings. Studies utilizing data from large patient studies and applying state-of-the-art genomic and proteomic analysis are also encouraged. The grant encourages research ideas that address the recommendations of the congressionally mandated Metastatic Cancer Task Force. It also encourages innovative research involving nuclear medicine and related techniques to improve diagnosis, treatment, and health outcomes of active-duty Service Members and their Families. Applications from investigators within the military services and collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs, and other federal government agencies are highly encouraged. Adherence to rigorous study design and reporting standards is expected. The anticipated total program funding for this grant is $53.76 million, with an expected number of 28 awards. The maximum direct costs budgeted for the entire period of performance should not exceed $1.2 million. The funding is contingent upon the availability of federal funds and the quality of the applications. For more information and to apply, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507. The deadline for submission is July 19, 2024.